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Differences between Bipolar Depression (BD) and Unipolar Depression (UD) have been studied 
for years with controversial results. Bipolar Disorder is often misdiagnosed as Unipolar 
Depression when exploration of symptoms is not adequate enough. The objective of our study 
was to investigate a number of variables, which could differentiate UD and BD in a sample of 
patients assessed by the same methodology within the framework of a belgian multicenter 
study. All the patients were assessed with the COPE-Bipolar.COM software. It consists of a 
computerized tool for Clinical Outcome Measures and is part of the COPE-Bipolar program 
(Clinical Outcome and Psycho Education in Bipolar Disorders) and is intended to be used to 
improve the quality of management and treatment of Bipolar and Unipolar Disorders. COPE-
Bipolar.COM is composed of the following modules: Demographic Data, the MINI International 
Neuropsychiatric Interview, Current and Previous Psychotropic Treatment, Side Effects, Somatic 
Comorbidity, Family History of Psychiatric Disorders, Severity Scales, Quality of Life and 
Functioning and New Mood Episode. Baseline and outcome interviews appear as structured 
assessments. Data has in consequence a definite and highly organized structure. All the acquired 
data are been gathered and automatically exported to an Excel data sheet and then analyzed by 
using the SPSS statistical software. The current sample consists of 303 patients: 120 Unipolar 
patients (UP), 141 Bipolar patients Type I (BPI) and 42 Bipolar patients type II (BPII) for whom 
the complete structured interview was performed. Bipolar Depression (BD) is more severe and 
more recurrent than Unipolar Depression (UD). We found that the mean age of onset for the first 
depressive episode lifetime was earlier in BPI (25.63, sd = 12.10) and BPII (24.17, sd = 11.51) 
than in UP (29.43, sd = 14.1), p = 0.023. We also found differences in recurrence of depressive 
episodes (mean number of episodes): 6.35 (sd = 3.4) in BPI, 7.37 (sd = 3.6) in BPII and 4.49 (sd 
= 3.5) in UP; p < 0.000. We noticed a difference in the severity of the depressive episode for 
those patients who were depressed at baseline interview: a severe depressive episode was 
observed in 89.9% in BPI patients, 80% in BPII and 66.7% in UP; p < 0.000. BD patients were 
more melancholic: 71.7% in BPI, 76.2% in BPII and 54.2% in UP and more psychotic: 65.7% in 
BPI, 30% in BPII and 13.9% in UP; p < 0.000. Quantitative evaluation of the severity of the 
depression assessed by the Hamilton Scale (HAM-17) and the Montgomery and Asberg 
Depression Rating Scale (MADRS) shows that UD would be more “sad” than BD. 50.6% of UP had 
a score >3 on the item 1 of the HAM-17 (sad mood; p = 0.035). 69.9% had a score of at least 4 
on the MADRS item “apparent sadness” (p = 0.047). These results confirm that BD have an 
earlier age of onset and a higher rate of recurrence for depressive episodes which are more 
severe, melancholic and psychotic. These data confirm the burden of depression in BD both for 
severity and long term outcome. 
 
